Increased neutrophil insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced functional capacity in patients with untreated Laron syndrome

European Journal of Endocrinology

Volumn 136, Issue 1, 1997, Pages 92-95

  Bjerknes, Robert ^a   Vesterhus, Per ^b   Aarskog, Dagfinn ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b Vest Agder County Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CASE REPORT; FEMALE; GENE EXPRESSION; HORMONE RESISTANCE; HORMONE SUBSTITUTION; HUMAN; LARON SYNDROME; MALE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RESPIRATORY BURST; SCHOOL CHILD; SIGNAL TRANSDUCTION;

EID: 0031046824     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360092     Document Type: Article

References (17)

1. Laron Z. Disorders of growth hormone resistance in childhood. Current Opinions in Pediatrics 1993 5 474-480.
2. Laron Z. Prismatic cases. Journal of Clinical Endocrinology and Metabolism 1995 80 1526-1531.
3. Rosenfeld R, Rosenbloom AL & Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocrine Reviews 1994 15 369-390.
4. Merchav S, Tatarsky I & Hochberg Z. Enhancement of human granulupoiesis in vitro by biosynthetic insulin-like growth factor/ somatomedin C and human growth hormone. Journal of Clinical Investigation 1988 81 791-797.
5. Sara VR & Hall K. Insulin-like growth factors and their binding proteins. Physiological Reviews 1990 70 591-614.
6. Fu YK, Arkins S, Wang BS & Kelley KW. A novel role of growth hormone and insulin-like growth factor-I: Priming neutrophils for Superoxide anion secretion. Journal of Immtmology 1991 146 1602-1608.
7. Kelley KW, Arkins S & Li YM. Growth hormone, prolactin, and insulin-like growth factors: New jobs for old players. Brain Behavior and Immunity 1992 6 317-326.
8. Oh Y, Müller HL, Neely EK, Lamson G & Rosenfeld RG. New concepts in insulin-like growth factor receptor physiology. Growth and Regulation 1993 3 113-123.
9. Bjerknes R & Aarskog D. Priming of human polymorphonuclear neutrophilic leukocytes by insulin-like growth factor I: Increased phagocytic capacity, complement receptor expression, degranulation, and oxidative burst. Journal of Clinical Endocrinology and Metabolism 1995 80 1948-1955.
10. Zhao X, McBride BW, Trouten-Radford LM & Burton JH. Effects of insulin-like growth factor-I and its analogues on bovine hydrogen peroxide release by neutrophils and blastogenesis by mononuclear cells. Journal of Endocrinology 1993 139 259-265.
11. Blum WF, Cotteril AM, Postel-Vinay MC, Ranke MB, Savage MO & Wilton P. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: Solutions and pitfalls. Acta Paediatrica 1994 S399 117-124.
12. Bjerknes R, Bassøe C-F, Sjursen H, Lærum OD & Solberg CO. Flow cytometry for the study of phagocyte functions. Reviews of Infectious Diseases 1989 11 16-33.
13. Eshet R, Klinger B, Silbergeld A & Laron Z. Modulation of insulin-like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS). Regulatory Peptides 1993 48 233-239.
14. Eshet R, Dux Z, Silbergeld A, Koren R, Klinger B & Laron Z. Erythrocytes from patients with low serum concentration of IGF-I have an increase in receptor sites for IGF-I. Acta Endocrinologica 1991 125 354-358.
15. Hochberg Z, Hertz P, Colin V, Ish-Shalom S, Yeshurun D, Youdim MBH & Amit T, The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor I and IGF-I receptors in obesity and anorexia nervosa. Metabolism 1992 41 106-112.
16. Gallin JI. Goldstein IM & Snydennan R, eds. Inflammation - Basic Principles and Clinical Correlates, 2nd edn. New York: Raven Press, 1992.
17. Beal A & Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. Journal of the American Medical Association 1994 271 226-233.